BeOne Medicines: Redefining Cancer Care

22 Visioni
Published
In this episode of Exceptional Leaders / Exceptional Ideas, Morgan Stanley’s Sean Laaman sits down with BeOne Medicines Co-Founder, Chairman and CEO John V. Oyler to explore how in house trials, global partnerships and a commitment to affordability are transforming oncology for patients everywhere.

https://mgstn.ly/3NiKIb2
Categoria
Oncology
Commenta per primo questo video.